12:01
2026-06-06
bigpharmasharma.com
ai-startups
Last Week Tonight in BioPharma: Week of June 1st, 2026
Revolution Medicines presented complete Phase 3 data for daraxonrasib at ASCO 2026, showing the drug cut the risk of death by 60% and nearly doubled median overall survival to 13.2 months versus 6.7 m…